铁超载对高脂饮食诱导的非酒精性脂肪肝病大鼠脂代谢的影响

doi:10.3969/j.issn.1004-616x.2017.03.004

癌变·畸变·突变 ›› 2017, Vol. 29 ›› Issue (3): 179-183.doi: 10.3969/j.issn.1004-616x.2017.03.004

铁超载对高脂饮食诱导的非酒精性脂肪肝病大鼠脂代谢的影响

蔡静明, 沈洁, 曹玥, 孙梦云, 赵艳

哈尔滨医科大学公共卫生学院营养与食品卫生学教研室, 黑龙江哈尔滨 150081

收稿日期:2017-03-23 修回日期:2017-04-19 出版日期:2017-05-31 发布日期:2017-05-31
通讯作者: 赵艳,E-mail:amyzhaosb@163.com E-mail:amyzhaosb@163.com
作者简介:蔡静明,E-mail:13644607706@163.com。
基金资助:
国家自然科学基金（81273062，81573136）

Effects of iron overload and high fat diet on lipid metabolism in nonalcoholic fatty liver disease in rats

CAI Jingming, SHEN Jie, CAO Yue, SUN Mengyun, ZHAO Yan

Department of Nutrition and Food Hygiene, School of Public Health, Harbin Medical University, Harbin 150081, Heilongjiang, China

Received:2017-03-23 Revised:2017-04-19 Online:2017-05-31 Published:2017-05-31

摘要/Abstract

摘要： 目的：探讨铁超载对非酒精性脂肪肝病（NAFLD）模型大鼠脂代谢的影响。方法：48只雄性SD大鼠随机分成空白对照组（基础饲料）、高铁组（含1% FeSO₄的基础饲料）、高脂组（高脂饲料）、高脂低铁组（含0.5% FeSO₄的高脂饲料）、高脂高铁组（含1% FeSO₄的高脂饲料）。干预20周后，称取大鼠体质量；肝脏油红O染色观察肝脏脂质堆积情况；测定肝脏内甘油三酯（TG）含量；实时荧光定量PCR（qPCR）和Western blot分别检测大鼠肝脏中脂肪酸合成酶（FAS）、肉碱酰基转位酶Ⅰ（CPT1）的mRNA和蛋白表达水平。结果：与对照组比较，高脂膳食20周使大鼠体质量、肝脏TG含量均明显增加（P均 < 0.05），并促进TG在肝脏的沉积；且FAS的mRNA和蛋白水平均增加，CPT1的mRNA和蛋白水平均降低（P均 < 0.05）。与高脂组比较，高脂高铁组大鼠肝脏TG含量明显增加（P < 0.05）；FAS的mRNA和蛋白水平均显著增加，CPT1的mRNA和蛋白水平均降低（P均 < 0.05）。结论：铁超载能够促进NAFLD大鼠肝脏脂质堆积，加重脂代谢紊乱，促进NAFLD病程进展。

关键词: 非酒精性脂肪肝病, 铁超载, 游离脂肪酸, 脂代谢

Abstract: OBJECTIVE:To explore the effects of high fat combined with iron overload diet in rats on lipid metabolism in the development of nonalcoholic fatty liver disease (NAFLD). METHODS:Forty-eight male SD rats were randomly divided into 5 groups:normal control,high iron diet (high iron diet containing 1% FeSO₄),high fat diet (high fat diet),high fat and low dose iron supplement diet (high fat diet containing 0.5% FeSO₄),high fat and high dosage iron diet (high fat diet containing 1% FeSO₄) groups. These rats were sacrificed after 20 weeks. Their body weights were measured and liver lipid accumulation was observed by oil red O staining. The content of liver TG was measured. Quantitative real-time PCR (qPCR) were used to detect mRNA levels of fatty acid synthase (FAS) and carnitine palmitoyl transferase 1 (CPT1) and their proteins were detected by Western blot. RESULTS:Compared with the normal control group,the body weight and liver TG content in the high fat group were increased significantly (P < 0.05) and high fat diet promoted the deposition of TG in the liver. Additionally,the mRNA level and protein expression of FAS were significantly increased,but the mRNA level and protein expression of CPT1 were significantly decreased (P < 0.05). Compared with the high fat group,the content of liver TG in the high fat and high dosage iron supplement group was significantly increased (P < 0.05). The mRNA and protein level of FAS were increased significantly and the mRNA and protein level of CPT1 were significantly decreased (P < 0.05). CONCLUSION:Iron overload further promoted the deposition of TG in the liver,the disorder of lipid metabolism and the development of NAFLD.

Key words: nonalcoholic fatty liver disease, iron overload, free fatty acids, lipid metabolism

中图分类号:

R994.4

蔡静明, 沈洁, 曹玥, 孙梦云, 赵艳. 铁超载对高脂饮食诱导的非酒精性脂肪肝病大鼠脂代谢的影响[J]. 癌变·畸变·突变, 2017, 29(3): 179-183.

CAI Jingming, SHEN Jie, CAO Yue, SUN Mengyun, ZHAO Yan. Effects of iron overload and high fat diet on lipid metabolism in nonalcoholic fatty liver disease in rats[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2017, 29(3): 179-183.

参考文献

[1] LOREAL O,CAVEY T,BARDOU-JACQUET E,et al. Iron,hepcidin,and the metal connection[J]. Front Pharmacol, 2014,5:128.
[2] LAWEN A,LANE D J. Mammalian iron homeostasis in health and disease:uptake,storage,transport,and molecular mecha-nisms of action[J]. Antioxid Redox Signal,2013, 18(18):2473-507.
[3] FLEMING RE,PONKA P. Iron overload in human disease[J]. N Engl J Med,2012,366(4):348-359.
[4] SIMCOX J A,MCCLAIN D A. Iron and diabetes risk[J]. Cell Metab,2013,17(3):329-41.
[5] MILTO I V,SUHODOLO I V,PROKOPIEVA V D,et al. Molecular and cellular bases of iron metabolism in humans[J]. Biochemistry (Mosc),2016,81(6):549-564.
[6] GHAMARCHEHREH M E,JONAIDI-JAFARI N,BIGDELI M,et al. Iron status and metabolic syndrome in patients with non-alcoholic fatty liver disease[J]. Middle East J Dig Dis, 2016,8(1):31-38.
[7] BYRNE C D,TARGHER G. NAFLD:a multisystem disease[J]. J Hepatol,2015,62(Sup 1):47-64.
[8] TARGHER G,CHONCHOL M B,BYRNE C D. CKD and nonalcoholic fatty liver disease[J]. Am J Kidney Dis,2014, 64(4):638-652.
[9] NEUMAN M G,FRENCH S W,FRENCH B A,et al. Alcoholic and non-alcoholic steatohepatitis[J]. Exp Mol Pathol, 2014,97(3):492-510.
[10] BECHMANN L P,HANNIVOORT R A,GERKEN G,et al. The interaction of hepatic lipid and glucose metabolism in liver diseases[J]. J Hepatol,2012,56(4):952-964.
[11] CSAKI L S,REUE K. Lipins:multifunctional lipid metabolism proteins[J]. Annu Rev Nutr,2010,30:257-272.
[12] BELLANTI F,VILLANI R,FACCIORUSSO A,et al. Lipid oxidation products in the pathogenesis of nonalcoholic steato-hepatitis[J]. Free Radic Biol Med,2017,11(18):891-895.
[13] THOMAS C,MACKEY M M,DIAZ A A,et al. Hydroxyl radical is produced via the Fenton reaction in submitochondrial particles under oxidative stress:implications for diseases associated with iron accumulation[J]. Redox Rep,2009, 14(3):102-108.
[14] LIVAK K J,SCHMITTGEN T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method[J]. Methods,2001,25(4):402-408.
[15] SAFWAT G M,PISANO S,D'AMORE E,et al. Induction of non-alcoholic fatty liver disease and insulin resistance by feeding a high-fat diet in rats:does coenzyme Q monomethyl ether have a modulatory effect?[J]. Nutrition,2009,25(11/12):1157-1168.
[16] TAN Y,SUN L Q,KAMAL M A,et al. Suppression of retinol-binding protein 4 with RNA oligonucleotide prevents high-fat diet-induced metabolic syndrome and non-alcoholic fatty liver disease in mice[J]. Biochim Biophys Acta,2011, 1811(12):1045-1053.
[17] JUN D W,CHO W K,JUN J H,et al. Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction[J]. Liver Int,2011,31(9):1315-1324.
[18] FELDSTEIN A E. Novel insights into the pathophysiology of nonalcoholic fatty liver disease[J]. Semin Liver Dis,2010, 30(4):391-401.
[19] NGUYEN P,LERAY V,DIEZ M,et al. Liver lipid metabolism[J]. J Anim Physiol Anim Nutr (Berl),2008, 92(3):272-283.
[20] AMENGUAL J,PETROV P,BONET M L,et al. Induction of carnitine palmitoyl transferase 1 and fatty acid oxidation by retinoic acid in HepG2 cells[J]. Int J Biochem Cell Biol, 2012,44(11):2019-2027.
[21] LIN X,SHIM K,ODLE J. Carnitine palmitoyltransferase I control of acetogenesis,the major pathway of fatty acid {beta}-oxidation in liver of neonatal swine[J]. Am J Physiol Regul Integr Comp Physiol,2010,298(5):1435-1443.

铁超载对高脂饮食诱导的非酒精性脂肪肝病大鼠脂代谢的影响

Effects of iron overload and high fat diet on lipid metabolism in nonalcoholic fatty liver disease in rats

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 4

编辑推荐

Metrics

本文评价

[1]	龙子, 樊隽澍, 吴光源, 王欣, 海春旭. 低剂量双酚A通过调控PPARγ致小鼠糖脂代谢紊乱的研究[J]. 癌变·畸变·突变, 2020, 32(4): 245-255.
[2]	廖鼐, 龙子, 海春旭, 王欣. 2,3,7,8-四氯二苯并二噁英染毒或联合高脂饮食致小鼠糖脂代谢紊乱的实验研究[J]. 癌变·畸变·突变, 2019, 31(2): 111-118.
[3]	曹玥, 孙梦云, 蔡静明, 张立加, 赵艳. miR-34a及其下游基因在铁超载大鼠非酒精性脂肪肝发生过程中的作用[J]. 癌变·畸变·突变, 2018, 30(5): 378-383.
[4]	沈洁, 蔡静明, 孙梦云, 曹玥, 赵艳. 铁超载对非酒精性脂肪肝病HepG2细胞模型中Hepcidin和Fpn-1的影响[J]. 癌变·畸变·突变, 2017, 29(3): 184-188.